12/02/2022 /
Here, we review the ongoing impacts of the pandemic on HVET services amongst several different providers who used different initial models of HVET.
11/29/2022 /
Genetic causes are responsible for seizures in 30 percent or more of infants and toddlers and about 10 percent of adults with epilepsy, but genetic testing is not routinely done.
11/28/2022 /
“We have found a very promising new drug candidate for treating epilepsy that works through a new mechanism—blocking connexin hemichannels.
11/23/2022 /
“We’re getting more insights into specific brain networks. We’re not waiting around for seizures to happen.”
11/22/2022 /
“It’s possible that the trauma of the surgical procedure further stimulates the immune system in the brain to attack healthy brain tissue.”
11/21/2022 /
The rate of new cases of epilepsy or seizures was 0.94% in the people who had COVID, compared with 0.6% in those who had influenza. While the overall risk of seizures is therefore small, these cases show that people who had COVID were 55% more likely to develop epilepsy or seizures over the next six months than people who had influenza.
11/18/2022 /
In this study it was demonstrated that levetiracetam (LEV) had a significantly better effectiveness (i.e. less often ASM treatment failure for any reason or due to adverse effects) compared to enzyme-inducing anti-seizure medications (EIASMs), supporting the current neuro-oncology guideline recommendations to avoid EIASMs in glioma patients.
11/16/2022 /
Diagnosed in only a few hundred people worldwide, this disease is caused by a congenital deficiency in a protein called glucose transporter type 1, which brings blood sugar into cells to use as fuel.
